3,881
edits
Changes
HAEM5:Volunteer Assignments and Opportunities (view source)
Revision as of 20:39, 17 December 2023
, 20:39, 17 December 2023no edit summary
|Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive
|Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive
|Jack Reid, MD (University of California, Irvine) Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine)
|Jack Reid, MD (University of California, Irvine) Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine)
|
|Complete
|Date page was created
|Date page was created
|
|
|Chronic Neutrophilic Leukemia (CNL)
|Chronic Neutrophilic Leukemia (CNL)
|Anamaria Munteanu, MD, Ph.D**, Harbor-UCLA Medical Center, Joseph J. Merlo Jr, MD. Ph.D**, Ashion Analytics, Fabiola Quintero-Rivera, University of California Irvine <nowiki>**</nowiki>contributed equally
|Anamaria Munteanu, MD, Ph.D**, Harbor-UCLA Medical Center, Joseph J. Merlo Jr, MD. Ph.D**, Ashion Analytics, Fabiola Quintero-Rivera, University of California Irvine <nowiki>**</nowiki>contributed equally
|
|Complete
|Date page was created
|Date page was created
|
|
|Chronic Eosinophilic Leukemia, Not Otherwise Specified
|Chronic Eosinophilic Leukemia, Not Otherwise Specified
|Chelsea D. Kramish; Daynna J.Wolff
|Chelsea D. Kramish; Daynna J.Wolff
|
|complete/pending faculty review
|
|
|
|
|Polycythemia Vera (PV)
|Polycythemia Vera (PV)
|Gokce A. Toruner, MD, PhD UT MD Anderson Cancer Center
|Gokce A. Toruner, MD, PhD UT MD Anderson Cancer Center
|
|Complete
|
|
|
|
|Essential Thrombocythemia (ET)
|Essential Thrombocythemia (ET)
|Rebecca Smith, PhD, Director, Genetics Associates, Nashville, TN
|Rebecca Smith, PhD, Director, Genetics Associates, Nashville, TN
|
|Complete
|
|
|
|
|-
|-
|Primary myelofibrosis||Disease||T. Niroshi Senaratne, UCLA|| || || || ||FQR|| ||
|Primary myelofibrosis||Disease|| || || || || ||FQR|| ||
|
|Primary Myelofibrosis (PMF)
|
|T. Niroshi Senaratne, UCLA
|
|Complete
|8/4/2020 before submission<br />
|8/4/2020 before submission<br />
|
|